[EN] TRIAZINETRIONE DERIVATIVES AND THEIR USE AS MODULATORS OF NEUROTROPHIN RECEPTOR AND RECEPTOR TYROSINE KINASES<br/>[FR] DÉRIVÉS DE TRIAZINETRIONE ET LEUR UTILISATION EN TANT QUE MODULATEURS DU RÉCEPTEUR DE LA NEUROTROPHINE ET DE TYROSINES KINASES RÉCEPTRICES
申请人:STIFTELSEN ALZECURE
公开号:WO2018115891A1
公开(公告)日:2018-06-28
The present invention relates to a new use of 4-phenoxy-phenyl-1,3,5-triazine derivatives or pharmaceutically acceptable salts thereof, according to formula I, wherein R1, R2 and U have meanings as provided in the description, as medicaments for the treatment and/or prevention of diseases characterised by impaired signalling of neurotrophins and/or other trophic factors. In particular, the invention relates to the treatment of such diseases in patients with the Val66Met mutation in the brain-derived neurotrophic factor gene.
本发明涉及4-苯氧基-苯基-1,3,5-三嗪衍生物或其药学上可接受的盐的新用途,其化学式为I,其中R1、R2和U的含义如描述中所提供的,作为治疗和/或预防神经营养因子和/或其他营养因子信号受损的疾病的药物。特别地,本发明涉及治疗患有脑源性神经营养因子基因中Val66Met突变的患者的这种疾病。